Imagine a world where obesity and diabetes research is held back by a simple yet pervasive mistake. That's the reality Alexander Banks, PhD, a leading metabolism expert at Beth Israel Deaconess Medical Center (BIDMC), aims to change. Banks, who also co-directs BIDMC’s Systemic Effects of Metabolic Disease Hub and directs the Energy Balance Core (a facility dedicated to tracking animal metabolism), is on a mission to standardize how we measure and analyze energy expenditure in research. But here's where it gets controversial: for decades, scientists have been using inconsistent methods, leading to unreliable comparisons across studies. And this is the part most people miss: this inconsistency could be skewing our understanding of obesity, diabetes, and weight-loss treatments.
Banks recently spearheaded an international collaboration of 79 scientists to publish a landmark paper in Nature Metabolism (https://www.nature.com/articles/s42255-025-01360-4). This paper establishes global standards for measuring metabolism in animals, a critical step as new weight-loss medications like GLP-1 receptor agonists (e.g., semaglutide) gain traction. For over a century, researchers have relied on indirect calorimetry—measuring oxygen consumption and carbon dioxide production—to estimate energy expenditure. However, differing analysis methods have made it nearly impossible to compare results across studies.
The new framework provides a unified approach, ensuring experiments are accurate, reproducible, and comparable. This couldn’t come at a better time, as the world grapples with rising obesity rates and the urgent need for effective treatments. But why now? Banks explains, “It’s a milestone for our field, particularly timely given advances in obesity therapeutics and new weight-loss medicines.”
Here’s the kicker: the problem wasn’t just about outdated methods—it was about inertia. Despite a decade-old consensus on the correct analysis approach, many researchers continued using flawed systems. To address this, Banks’ team developed CalR (https://calrapp.org/), a free web application that simplifies accurate data analysis. With over 85,000 uses worldwide, CalR proved the field was ready for change.
But how did 79 scientists come together? It started with frustration. Banks recalls, “Everyone has reached the boiling point because you don’t know what data you can trust—it depends on how the data were analyzed.” Instead of another opinion piece, they formed the International Indirect Calorimetry Consensus Committee, representing experts from the U.S., Brazil, Chile, Canada, UK, France, Germany, Korea, China, Japan, and more.
Now, here’s where it gets even more intriguing: this standardization isn’t just about accuracy—it’s about clarity. For instance, early studies on GLP-1 agonists, analyzed incorrectly, suggested they boosted energy expenditure. Proper analysis revealed the real effect was reduced food intake—a critical distinction. Similarly, studies on brown fat and thermogenesis often overstated effects due to flawed methods. The new standards ensure we’re not just measuring metabolism but understanding it correctly.
But what about older studies? Banks admits, “Most can’t be reanalyzed, so we may have to reconsider some of their conclusions.” While these studies weren’t wrong for their time, they highlight the need for consistent methods moving forward. The key difference? The new approach accounts for body composition, ensuring comparisons aren’t misleading.
Here’s a thought-provoking question for you: As we standardize metabolism research, should we re-evaluate past findings that relied on outdated methods? Or is it enough to move forward with the new standards?
Banks remains optimistic about the future. “There’s still so much to learn about metabolism,” he says. While studying humans is challenging—think whole-room calorimetry chambers or doubly labeled water methods—rodent studies offer continuous, detailed data, making them invaluable. This consensus paper, he believes, will be a milestone for the field.
So, what’s next? As Banks and his colleagues foster collaboration across institutions like Joslin Diabetes Center and Boston Children’s Hospital, they’re not just setting standards—they’re reshaping how we tackle metabolic diseases. But here’s the real question: Will this consensus spark a revolution in obesity and diabetes research, or will old habits die hard? Let us know your thoughts in the comments—we’d love to hear your take on this game-changing development.
